How Bitcoin Could React To Promising Moderna Vaccine
This morning, news broke that Cambridge, Massachusetts-based biotech firm Moderna, had reached 94.5% efficiency in preventing the onset of COVID with their in-the-works vaccine. Bitcoin responded with a rally, but the last time around when Pfizer revealed their success rate, the cryptocurrency plummeted by over $1,000. With the likelihood of an effective vaccine growing, and […]
Related News
Bitcoin was trading higher ahead of the New York opening bell Monday but risked shedding its intraday gains on Moderna’s latest announcement. The tech-savvy pharmaceutical firm updated earlier Monday that its experimental coronavirus vaccine is 94.5 percent effective in protecting people from catching the infection. That marked the second successful trial seven days after Pfizer […]
Coronavirus and renewable energy are among the triggers of huge dividends for holders of certain equities this year. Bitcoin (BTC) has wowed investors with all-time highs and year-to-date returns of over 200% — but there are stocks that still beat it.As of Dec. 22, markets' data shows that no fewer than five companies’ stocks have given investors better rewards than a Bitcoin position since the start of 2020.BTC/USD vs. TSLA, ZM, PTON, MRNA, ENPH. Source: TradingviewPeloton Interactive Inc.First pitting itself against Bitcoin and winning is an unlikely success story — fitness equipment....
Bitcoin rose Monday, putting itself back on track to retest its record high after promising results on a coronavirus vaccine reinforced hopes of an economic rebound next year. The spot BTC/USD exchange rate climbed 0.95 percent after the benchmark cryptocurrency briefly snapped its six-week winning streak on Sunday. The pair touched an intraday high of […]
A vaccine merely triggers inflation, allowing more institutions/investors to exchange their cash holdings for the cryptocurrency.
Price reaction to vaccine breakthrough renews dialogue over whether bitcoin trades like a risk-on asset, inflation hedge or neither.